Concepts (215)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 13 | 2015 | 400 | 3.290 |
Why?
|
| Liver | 16 | 2022 | 1118 | 2.950 |
Why?
|
| Mitochondria, Liver | 6 | 2020 | 148 | 1.830 |
Why?
|
| Cyclosporine | 6 | 2013 | 121 | 1.780 |
Why?
|
| Nitric Oxide Synthase Type II | 6 | 2015 | 201 | 1.740 |
Why?
|
| Graft Survival | 6 | 2015 | 465 | 1.530 |
Why?
|
| Acetaminophen | 2 | 2022 | 111 | 1.510 |
Why?
|
| Aldehyde Dehydrogenase, Mitochondrial | 2 | 2020 | 21 | 1.450 |
Why?
|
| Chemical and Drug Induced Liver Injury | 2 | 2022 | 131 | 1.430 |
Why?
|
| Liver Regeneration | 5 | 2014 | 38 | 1.390 |
Why?
|
| Mitochondria | 8 | 2015 | 643 | 1.250 |
Why?
|
| Ethanol | 5 | 2018 | 892 | 1.130 |
Why?
|
| Necrosis | 6 | 2022 | 239 | 1.090 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 2 | 2015 | 11 | 0.910 |
Why?
|
| Fatty Liver | 3 | 2014 | 97 | 0.880 |
Why?
|
| Reperfusion Injury | 5 | 2014 | 320 | 0.850 |
Why?
|
| Kidney | 4 | 2015 | 945 | 0.840 |
Why?
|
| Enzyme Inhibitors | 4 | 2012 | 659 | 0.790 |
Why?
|
| Animals | 28 | 2022 | 20877 | 0.770 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2012 | 200 | 0.740 |
Why?
|
| Alanine Transaminase | 9 | 2020 | 137 | 0.710 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2020 | 45 | 0.710 |
Why?
|
| Bile Ducts | 1 | 2019 | 59 | 0.700 |
Why?
|
| Rats, Inbred Lew | 8 | 2012 | 150 | 0.690 |
Why?
|
| Hepatitis, Alcoholic | 1 | 2018 | 5 | 0.670 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2018 | 27 | 0.660 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 4 | 2011 | 41 | 0.590 |
Why?
|
| Central Nervous System Depressants | 1 | 2018 | 182 | 0.590 |
Why?
|
| Phenols | 3 | 2022 | 73 | 0.590 |
Why?
|
| Tyrosine | 4 | 2012 | 196 | 0.570 |
Why?
|
| Rats | 12 | 2015 | 5300 | 0.560 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 301 | 0.560 |
Why?
|
| Polyphenols | 3 | 2013 | 34 | 0.550 |
Why?
|
| Adamantane | 2 | 2012 | 40 | 0.530 |
Why?
|
| Mice | 10 | 2022 | 8472 | 0.520 |
Why?
|
| Death | 2 | 2015 | 38 | 0.510 |
Why?
|
| Acute Lung Injury | 1 | 2015 | 35 | 0.510 |
Why?
|
| Homeostasis | 1 | 2015 | 291 | 0.480 |
Why?
|
| Mitochondrial Turnover | 1 | 2013 | 3 | 0.470 |
Why?
|
| Pyridines | 2 | 2012 | 261 | 0.460 |
Why?
|
| Tea | 1 | 2013 | 23 | 0.460 |
Why?
|
| Mice, Inbred C57BL | 7 | 2022 | 2790 | 0.450 |
Why?
|
| Fatty Liver, Alcoholic | 1 | 2012 | 5 | 0.450 |
Why?
|
| Suramin | 1 | 2012 | 9 | 0.450 |
Why?
|
| Hepatectomy | 2 | 2014 | 58 | 0.410 |
Why?
|
| Mitochondrial Diseases | 2 | 2011 | 24 | 0.410 |
Why?
|
| Oxidative Stress | 4 | 2022 | 718 | 0.390 |
Why?
|
| Camellia sinensis | 2 | 2010 | 9 | 0.390 |
Why?
|
| Bilirubin | 4 | 2012 | 51 | 0.370 |
Why?
|
| Smad7 Protein | 1 | 2010 | 11 | 0.370 |
Why?
|
| Flavonoids | 2 | 2010 | 109 | 0.370 |
Why?
|
| Benzodioxoles | 2 | 2020 | 30 | 0.360 |
Why?
|
| Organ Size | 4 | 2012 | 242 | 0.360 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2010 | 126 | 0.340 |
Why?
|
| Hepatocytes | 4 | 2014 | 205 | 0.330 |
Why?
|
| Benzamides | 2 | 2020 | 156 | 0.330 |
Why?
|
| Kidney Diseases | 2 | 2013 | 307 | 0.330 |
Why?
|
| Mitochondrial Membranes | 1 | 2008 | 45 | 0.330 |
Why?
|
| Ischemic Preconditioning | 1 | 2008 | 31 | 0.320 |
Why?
|
| Cholestasis | 1 | 2008 | 90 | 0.320 |
Why?
|
| Male | 16 | 2020 | 37281 | 0.320 |
Why?
|
| Reactive Nitrogen Species | 3 | 2012 | 32 | 0.300 |
Why?
|
| Permeability | 3 | 2014 | 131 | 0.280 |
Why?
|
| Tacrolimus | 1 | 2006 | 127 | 0.260 |
Why?
|
| Cell Death | 3 | 2011 | 329 | 0.260 |
Why?
|
| RNA, Messenger | 3 | 2015 | 1663 | 0.260 |
Why?
|
| Oxidative Phosphorylation | 2 | 2015 | 54 | 0.250 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2015 | 51 | 0.250 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 2 | 2015 | 13 | 0.250 |
Why?
|
| Signal Transduction | 3 | 2014 | 2688 | 0.250 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 1174 | 0.240 |
Why?
|
| Adenosine Triphosphate | 3 | 2014 | 314 | 0.230 |
Why?
|
| Caspase 3 | 3 | 2014 | 233 | 0.220 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2022 | 10 | 0.220 |
Why?
|
| Glycosides | 1 | 2022 | 14 | 0.220 |
Why?
|
| Shock, Hemorrhagic | 2 | 2014 | 33 | 0.220 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 2550 | 0.220 |
Why?
|
| Acute Kidney Injury | 2 | 2015 | 232 | 0.210 |
Why?
|
| Apoptosis | 5 | 2015 | 1640 | 0.210 |
Why?
|
| Mice, Knockout | 3 | 2015 | 1692 | 0.210 |
Why?
|
| Nitrites | 2 | 2012 | 53 | 0.200 |
Why?
|
| Nitrates | 2 | 2012 | 61 | 0.200 |
Why?
|
| Drug Combinations | 1 | 2022 | 304 | 0.200 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2012 | 93 | 0.200 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2014 | 71 | 0.200 |
Why?
|
| Minocycline | 2 | 2014 | 61 | 0.200 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2022 | 110 | 0.200 |
Why?
|
| Lysophospholipids | 2 | 2012 | 209 | 0.190 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2020 | 27 | 0.180 |
Why?
|
| Transcription Factors | 2 | 2015 | 753 | 0.180 |
Why?
|
| Aspartate Aminotransferases | 1 | 2020 | 87 | 0.180 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2011 | 22 | 0.180 |
Why?
|
| Mitochondrial Proteins | 2 | 2013 | 113 | 0.180 |
Why?
|
| Sphingosine | 2 | 2012 | 315 | 0.180 |
Why?
|
| Ligation | 1 | 2019 | 83 | 0.180 |
Why?
|
| Reactive Oxygen Species | 2 | 2012 | 499 | 0.170 |
Why?
|
| Enzyme Activation | 1 | 2020 | 791 | 0.160 |
Why?
|
| Aldehydes | 2 | 2008 | 34 | 0.160 |
Why?
|
| Free Radicals | 2 | 2008 | 65 | 0.150 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 189 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2013 | 2083 | 0.150 |
Why?
|
| Tetracycline | 2 | 2014 | 29 | 0.150 |
Why?
|
| Resuscitation | 2 | 2014 | 77 | 0.140 |
Why?
|
| Mitochondrial Dynamics | 1 | 2015 | 17 | 0.140 |
Why?
|
| Organelle Biogenesis | 1 | 2015 | 34 | 0.140 |
Why?
|
| Graft Rejection | 2 | 2010 | 458 | 0.130 |
Why?
|
| Inflammation | 2 | 2012 | 1030 | 0.130 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2015 | 160 | 0.130 |
Why?
|
| Immunoblotting | 1 | 2015 | 254 | 0.130 |
Why?
|
| Multiple Organ Failure | 1 | 2014 | 36 | 0.130 |
Why?
|
| Cation Transport Proteins | 1 | 2014 | 11 | 0.120 |
Why?
|
| Doxycycline | 1 | 2014 | 49 | 0.120 |
Why?
|
| Protective Agents | 1 | 2014 | 36 | 0.120 |
Why?
|
| Fluid Therapy | 1 | 2014 | 59 | 0.120 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 337 | 0.120 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2014 | 62 | 0.120 |
Why?
|
| Intracellular Membranes | 1 | 2014 | 86 | 0.120 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2014 | 32 | 0.120 |
Why?
|
| Electron Transport Complex I | 1 | 2013 | 20 | 0.120 |
Why?
|
| Gene Dosage | 1 | 2013 | 47 | 0.120 |
Why?
|
| Kidney Function Tests | 1 | 2013 | 114 | 0.110 |
Why?
|
| Complement Activation | 1 | 2014 | 145 | 0.110 |
Why?
|
| Hypoxia | 1 | 2014 | 169 | 0.110 |
Why?
|
| DNA, Mitochondrial | 1 | 2013 | 84 | 0.110 |
Why?
|
| Raffinose | 1 | 2012 | 28 | 0.110 |
Why?
|
| Amidines | 1 | 2012 | 7 | 0.110 |
Why?
|
| Allopurinol | 1 | 2012 | 36 | 0.110 |
Why?
|
| Benzylamines | 1 | 2012 | 28 | 0.110 |
Why?
|
| Biomarkers | 2 | 2015 | 1593 | 0.110 |
Why?
|
| Organ Preservation Solutions | 1 | 2012 | 45 | 0.110 |
Why?
|
| Liver Function Tests | 1 | 2012 | 114 | 0.110 |
Why?
|
| Leukocytes | 1 | 2012 | 99 | 0.110 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 140 | 0.100 |
Why?
|
| Chemokines | 1 | 2012 | 119 | 0.100 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2012 | 114 | 0.100 |
Why?
|
| Adenosine | 1 | 2012 | 165 | 0.100 |
Why?
|
| Voltage-Dependent Anion Channels | 1 | 2011 | 40 | 0.100 |
Why?
|
| Glycolysis | 1 | 2011 | 79 | 0.100 |
Why?
|
| Fluoresceins | 1 | 2011 | 31 | 0.100 |
Why?
|
| Cell Adhesion Molecules | 1 | 2012 | 199 | 0.100 |
Why?
|
| Cytochromes c | 1 | 2011 | 75 | 0.100 |
Why?
|
| Imines | 1 | 2010 | 6 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2010 | 17 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 196 | 0.100 |
Why?
|
| Phytotherapy | 2 | 2010 | 53 | 0.100 |
Why?
|
| Peroxynitrous Acid | 1 | 2010 | 55 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2012 | 432 | 0.090 |
Why?
|
| In Vitro Techniques | 1 | 2011 | 765 | 0.090 |
Why?
|
| Glutathione | 1 | 2012 | 343 | 0.090 |
Why?
|
| Lac Operon | 1 | 2010 | 54 | 0.090 |
Why?
|
| Sutures | 1 | 2010 | 32 | 0.090 |
Why?
|
| Smad3 Protein | 1 | 2010 | 33 | 0.090 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2010 | 55 | 0.090 |
Why?
|
| Smad2 Protein | 1 | 2010 | 42 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1745 | 0.090 |
Why?
|
| beta-Galactosidase | 1 | 2010 | 88 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2012 | 682 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 97 | 0.090 |
Why?
|
| Diet | 1 | 2013 | 513 | 0.090 |
Why?
|
| Triglycerides | 1 | 2010 | 184 | 0.090 |
Why?
|
| Gene Expression | 1 | 2012 | 770 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 434 | 0.090 |
Why?
|
| Plant Extracts | 1 | 2010 | 122 | 0.090 |
Why?
|
| Adenoviridae | 1 | 2010 | 295 | 0.090 |
Why?
|
| Gene Transfer Techniques | 1 | 2010 | 173 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 700 | 0.090 |
Why?
|
| Protoporphyrins | 1 | 2008 | 10 | 0.080 |
Why?
|
| Hydroxybenzoates | 1 | 2008 | 9 | 0.080 |
Why?
|
| Insulin | 1 | 2012 | 617 | 0.080 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2008 | 17 | 0.080 |
Why?
|
| Metalloporphyrins | 1 | 2008 | 25 | 0.080 |
Why?
|
| Heme Oxygenase-1 | 1 | 2008 | 40 | 0.080 |
Why?
|
| Transplantation, Isogeneic | 1 | 2008 | 19 | 0.080 |
Why?
|
| Hepatic Artery | 1 | 2008 | 25 | 0.080 |
Why?
|
| Liver Diseases | 1 | 2010 | 193 | 0.080 |
Why?
|
| Portal Vein | 1 | 2008 | 46 | 0.080 |
Why?
|
| Membrane Potentials | 1 | 2008 | 200 | 0.080 |
Why?
|
| Calcium | 2 | 2009 | 929 | 0.080 |
Why?
|
| Uncoupling Protein 2 | 1 | 2007 | 18 | 0.080 |
Why?
|
| Hyperbilirubinemia | 1 | 2007 | 12 | 0.080 |
Why?
|
| Electrophysiology | 1 | 2007 | 160 | 0.070 |
Why?
|
| Models, Animal | 1 | 2008 | 252 | 0.070 |
Why?
|
| Olive Oil | 1 | 2006 | 3 | 0.070 |
Why?
|
| Ion Channels | 1 | 2007 | 72 | 0.070 |
Why?
|
| Plant Oils | 1 | 2006 | 31 | 0.070 |
Why?
|
| Glycerol | 1 | 2006 | 26 | 0.070 |
Why?
|
| Fibrosis | 1 | 2008 | 371 | 0.070 |
Why?
|
| Oxygen | 1 | 2008 | 386 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2006 | 381 | 0.070 |
Why?
|
| Glomerular Filtration Rate | 1 | 2006 | 274 | 0.070 |
Why?
|
| Collagen | 1 | 2008 | 636 | 0.070 |
Why?
|
| Humans | 5 | 2019 | 68525 | 0.060 |
Why?
|
| Female | 4 | 2015 | 38015 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 514 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 1026 | 0.050 |
Why?
|
| Cytokines | 2 | 2014 | 866 | 0.040 |
Why?
|
| Cytoprotection | 1 | 2014 | 39 | 0.030 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2014 | 20 | 0.030 |
Why?
|
| CD59 Antigens | 1 | 2014 | 30 | 0.030 |
Why?
|
| Receptors, Complement 3d | 1 | 2014 | 45 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2014 | 282 | 0.030 |
Why?
|
| Liver Failure, Acute | 1 | 2014 | 49 | 0.030 |
Why?
|
| Creatinine | 1 | 2014 | 243 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2014 | 376 | 0.030 |
Why?
|
| Kinetics | 1 | 2014 | 1047 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2014 | 705 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2010 | 94 | 0.020 |
Why?
|
| Reye Syndrome | 1 | 2009 | 11 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2010 | 205 | 0.020 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2009 | 84 | 0.020 |
Why?
|
| Adenosine Diphosphate | 1 | 2008 | 66 | 0.020 |
Why?
|
| Models, Biological | 1 | 2011 | 981 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 4655 | 0.020 |
Why?
|
| Neoplasms | 1 | 2011 | 1660 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 14842 | 0.010 |
Why?
|